AssetMark Inc
VNDA icon

AssetMark Inc’s Vanda Pharmaceuticals VNDA Stock Holding History

AssetMark Inc’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31
Closed -$175 – 2367
2024
Q2 		$175 Hold
31
– – ﹤0.01% 2011
2024
Q1 		$127 Hold
31
– – ﹤0.01% 1811
2023
Q4 		$131 Sell
31
-26
-46% -$105 ﹤0.01% 1807
2023
Q3 		$246 Hold
57
– – ﹤0.01% 1617
2023
Q2 		$376 Hold
57
– – ﹤0.01% 1513
2023
Q1 		$387 Hold
57
– – ﹤0.01% 1506
2022
Q4 		$421 Sell
57
-28
-33% -$273 ﹤0.01% 1527
2022
Q3 		$1K Sell
85
-73,682
-100% -$778K ﹤0.01% 1491
2022
Q2 		$804K Buy
73,767
+15,400
+26% +$160K ﹤0.01% 551
2022
Q1 		$660K Buy
58,367
+14,357
+33% +$189K ﹤0.01% 570
2021
Q4 		$691K Sell
44,010
-2,756
-6% -$48K ﹤0.01% 486
2021
Q3 		$802K Buy
46,766
+3,949
+9% +$69.2K ﹤0.01% 408
2021
Q2 		$921K Buy
42,817
+5,392
+14% +$96.5K ﹤0.01% 394
2021
Q1 		$562K Buy
37,425
+8,722
+30% +$141K ﹤0.01% 431
2020
Q4 		$377K Buy
28,703
+4,644
+19% +$55.9K ﹤0.01% 471
2020
Q3 		$232K Buy
24,059
+11,752
+95% +$126K ﹤0.01% 501
2020
Q2 		$141K Buy
+12,307
New +$139K ﹤0.01% 535

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AssetMark Inc's VNDA Position: Q3 2024 in Review

AssetMark Inc sold out of Vanda Pharmaceuticals (VNDA) in Q3 2024, closing a stake of 31 shares — an estimated $175 sold.

AssetMark Inc first reported a position in VNDA in Q2 2020 and held it in 17 quarters. The position peaked at $921K in Q2 2021. 152 funds tracked by Wall St. Rank hold VNDA as of Q3 2024.

  • AssetMark Inc reported no remaining Vanda Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • AssetMark Inc sold 31 Vanda Pharmaceuticals shares in Q3 2024, an estimated $175.
  • AssetMark Inc first reported a position in Vanda Pharmaceuticals in Q2 2020 and held it in 17 quarters.
  • AssetMark Inc's Vanda Pharmaceuticals position peaked at $921K in Q2 2021.
  • 152 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2024.

Based on AssetMark Inc's 13F filing for Q3 2024, filed 1 Nov 2024.